Pepe S - Search Results

1

Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.

Avallone A, Di Gennaro E, Bruzzese F, Laus G, Delrio P, Caraglia M, Pepe S, Comella P, Budillon A. Avallone A, et al. Among authors: pepe s. Anticancer Drugs. 2007 Aug;18(7):781-91. doi: 10.1097/CAD.0b013e32809ef9b7. Anticancer Drugs. 2007. PMID: 17581300

2

Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.

Bruzzese F, Di Gennaro E, Avallone A, Pepe S, Arra C, Caraglia M, Tagliaferri P, Budillon A. Bruzzese F, et al. Among authors: pepe s. Clin Cancer Res. 2006 Jan 15;12(2):617-25. doi: 10.1158/1078-0432.CCR-05-1671. Clin Cancer Res. 2006. PMID: 16428508

3

Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed.

Di Gennaro E, Bruzzese F, Pepe S, Leone A, Delrio P, Subbarayan PR, Avallone A, Budillon A. Di Gennaro E, et al. Among authors: pepe s. Cancer Biol Ther. 2009 May;8(9):782-91. doi: 10.4161/cbt.8.9.8118. Epub 2009 May 9. Cancer Biol Ther. 2009. PMID: 19270508 Free article.

4

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.

Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A. Di Gennaro E, et al. Among authors: pepe s. J Cell Physiol. 2003 Apr;195(1):139-50. doi: 10.1002/jcp.10239. J Cell Physiol. 2003. PMID: 12599217

5

Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.

Morgillo F, Martinelli E, Troiani T, Laus G, Pepe S, Gridelli C, Ciardiello F. Morgillo F, et al. Among authors: pepe s. Mol Cancer Ther. 2008 Jun;7(6):1698-707. doi: 10.1158/1535-7163.MCT-07-0547. Mol Cancer Ther. 2008. PMID: 18566241

6

Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54(p53wt) and U251(p53mut) glioblastoma cell lines.

Cimmino G, Pepe S, Laus G, Chianese M, Prece D, Penitente R, Quesada P. Cimmino G, et al. Among authors: pepe s. Pharmacol Res. 2007 Jan;55(1):49-56. doi: 10.1016/j.phrs.2006.10.005. Epub 2006 Oct 20. Pharmacol Res. 2007. PMID: 17127074

7

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells.

Correale P, Caraglia M, Fabbrocini A, Guarrasi R, Pepe S, Patella V, Marone G, Pinto A, Bianco AR, Tagliaferri P. Correale P, et al. Among authors: pepe s. Anticancer Drugs. 1995 Apr;6(2):285-90. doi: 10.1097/00001813-199504000-00013. Anticancer Drugs. 1995. PMID: 7540894

8

Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells.

Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Beninati S, Lentini A, Pepe S, Boccellino M, Abbruzzese A. Caraglia M, et al. Among authors: pepe s. J Biochem. 2002 Jul;132(1):45-52. doi: 10.1093/oxfordjournals.jbchem.a003197. J Biochem. 2002. PMID: 12097159 Free article.

9

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.

Caponigro F, Romano C, Milano A, Solla R, Franchin G, Adamo V, Mari E, Morrica B, Pepe S. Caponigro F, et al. Among authors: pepe s. Anticancer Drugs. 2008 Aug;19(7):739-44. doi: 10.1097/CAD.0b013e32830676a8. Anticancer Drugs. 2008. PMID: 18594217 Clinical Trial.

10

5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells.

Caraglia M, Pinto A, Correale P, Zagonel V, Genua G, Leardi A, Pepe S, Bianco AR, Tagliaferri P. Caraglia M, et al. Among authors: pepe s. Ann Oncol. 1994 Mar;5(3):269-76. doi: 10.1093/oxfordjournals.annonc.a058806. Ann Oncol. 1994. PMID: 7514437 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters